Free Trial
TSE:FRX

Fennec Pharmaceuticals (FRX) Stock Price, News & Analysis

Fennec Pharmaceuticals logo
C$11.64 -0.34 (-2.84%)
As of 01:11 PM Eastern

About Fennec Pharmaceuticals Stock (TSE:FRX)

Key Stats

Today's Range
C$11.64
C$11.84
50-Day Range
C$8.66
C$12.50
52-Week Range
C$5.65
C$12.99
Volume
200 shs
Average Volume
1,092 shs
Market Capitalization
C$224.47 million
P/E Ratio
N/A
Dividend Yield
2.02%
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive FRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

FRX Stock News Headlines

Fennec Pharmaceuticals Inc. (FENC) - Yahoo Finance
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Fennec reports Q4 EPS (6c), consensus (13c)
Fennec Pharmaceuticals (FENC) Gets a Buy from Craig-Hallum
Fennec announces three executive appointments
See More Headlines

FRX Stock Analysis - Frequently Asked Questions

Fennec Pharmaceuticals' stock was trading at C$8.87 at the start of the year. Since then, FRX stock has increased by 31.2% and is now trading at C$11.64.

Fennec Pharmaceuticals Inc. (TSE:FRX) issued its quarterly earnings results on Thursday, November, 7th. The biopharmaceutical company reported ($0.29) earnings per share for the quarter, missing analysts' consensus estimates of ($0.19) by $0.10. Fennec Pharmaceuticals had a negative net margin of 2.30% and a positive trailing twelve-month return on equity of 29.94%.

Shares of FRX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fennec Pharmaceuticals investors own include Tilray Brands (TLRY), Aurora Cannabis (ACB), Encanto Potash (EPO), Adherex Technologies (FENC), Ocugen (OCGN), Passport Potash (PPI) and Workhorse Group (WKHS).

Company Calendar

Last Earnings
11/07/2024
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
TSE:FRX
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
19.28
P/E Growth
N/A
Net Income
-C$800.44 thousand
Net Margins
-2.30%
Pretax Margin
N/A
Return on Equity
29.94%
Return on Assets
8.88%

Debt

Debt-to-Equity Ratio
-620.83
Current Ratio
7.80
Quick Ratio
10.17

Sales & Book Value

Annual Sales
C$34.86 million
Price / Sales
6.44
Cash Flow
C$1.00 per share
Price / Cash Flow
11.66
Book Value
C($0.19) per share
Price / Book
-61.45

Miscellaneous

Outstanding Shares
19,284,690
Free Float
N/A
Market Cap
C$224.47 million
Optionable
Not Optionable
Beta
0.25
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (TSE:FRX) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners